Published in:
Volume 3 / Year 2014 / Issue 3

Subsequent entry biologics (biosimilars) in Canada: approaches to interchangeability and the extrapolation of indications and uses

Author(s): , ,
Page: 150-4

Abstract: The principles Health Canada use when extrapolating the indications and uses of a biosimilar product subsequent to a single clinical trial or limited number and scope of clinical trials… Read More »

Go Back Print